futuuropen

Tdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?

Name: Tdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
Creator: Forecast Insight

是

—

否

—

来源: Reproductive Health

Liquidity: $289.16

更新于: 2026年7月10日 06:01

请登录后评论。登录

无结果

评论 (0)